
Mattias Ohlsson
Professor

Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.
Author
Summary, in English
Bone Scan Index (BSI) is a quantitative measurement of tumour burden in the skeleton calculated from bone scan images. When analysed at the time of diagnosis, it has been shown to provide prognostic information on survival in men with metastatic prostate cancer (PCa). In this study, we evaluated the prognostic value of BSI during androgen deprivation therapy (ADT).
Department/s
- Nuclear medicine, Malmö
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- Urological cancer, Malmö
- Department of Astronomy and Theoretical Physics
- Clinical Physiology and Nuclear Medicine, Malmö
- EpiHealth: Epidemiology for Health
Publishing year
2014
Language
English
Publication/Series
EJNMMI Research
Volume
4
Full text
- Available as PDF - 842 kB
- Download statistics
Links
Document type
Journal article
Publisher
BioMed Central (BMC)
Topic
- Radiology, Nuclear Medicine and Medical Imaging
Status
Published
Research group
- Nuclear medicine, Malmö
- Urological cancer, Malmö
- Clinical Physiology, Malmö
ISBN/ISSN/Other
- ISSN: 2191-219X